Investor Updates: 3/24/2020
We wanted to share an update with our shareholders as we understand that, next to health and safety, your investments are top-of-mind as the equity markets have been affected by the current global status of COVID-19.
Our internal team remains focused on completing the necessary steps towards our public listing. We anticipate that our preliminary prospectus will be filed with the British Columbia Securities Commission (“BCSC”) within the coming weeks and, subject to the necessary approvals, we intend to file our listing applications on the Canadian Securities Exchange (“CSE”) and the US OTC Exchange.
The BCSC and CSE have both confirmed that, as of now, they will remain operating in order to service and support issuers and prospective issuers during the current global crisis. We do expect some delays during this process but remain focused to complete the necessary filings in a timely manner.
We also wanted to share news about Juva’s first active license, Juva Delivery in Redwood City, CA. California’s ‘shelter-in-place’ ordinance had been implemented at a county-level before it became a state-directed mandate. Juva Delivery was granted the necessary regulatory approvals to operate as cannabis was deemed medically necessary. In an interview by industry news leader, MJ Biz Daily, Juva’s CEO Doug Chloupek commented “Demand has increased exponentially… I have not had to furlough or lay off any employees. For that matter, we’ve been able to expedite the hiring of two new employees as of today.”
Juva Delivery has also commenced a strategic advertising campaign that launched earlier this week which consists of print ads debuting in regionally-targeted campaigns. As a result, Juva is the first cannabis company permitted to advertise in Modern Luxury’s exclusive Silicon Valley Magazine.
Another first for a cannabis business, Juva Delivery is now a member of the San Mateo County Convention and Visitors Bureau.
On Friday, Doug was featured in an interview with Forbes. We encourage you to read the article and learn a little bit more about Doug’s history and vision.
Interestingly, it was Forbes that led to the hire of the newest member of Juva’s executive team. After reading an interview with marketing professional Heidi Minx, Doug knew he had found the ideal person to lead Juva’s initiatives. In early January, Minx was appointed as the Vice President of Marketing.
Doug noted, “We’re fortunate to have been able to add Heidi to our team. She is well respected in the cannabis space and has strong connections with both legacy operators as well as those that are newer to the industry. Heidi’s work has given her incredible insight into the regulations that have evolved over the past few years and the nuanced compliance this industry requires. It’s rare to find such a seasoned marketing professional that understands the respective audiences a cannabis business today must communicate with.”
Minx will oversee the strategic launches and ongoing marketing efforts for Juva Cultivation, Juva Research, Juva Manufacturing, Juva Distribution, Juva Retail, and Juva Delivery. We encourage you to read more about her in the Forbes interview that inspired Doug!
From all of us at Juva, we wish you all the best with health, family and loved ones during these difficult times.
Forbes - Doug Chloupek Founder/CEO Of Juva Life Digs Deep Into 2020
“Within a year of opening my first dispensary, I quickly learned what I was supposed to (and so many before me have), cannabis is real medicine and we needed real science. Since there were no viable options, I set out to create a business to facilitate research and science around the manufacturing of cannabis formulations. I began that work in 2016 and opened the first licensed manufacturing business in Berkeley, California. I’ve since sold that along with my other businesses, and diligently worked to raise funds from a diverse, wide base, and have gathered an incredibly respected team of clinical researchers, scientists, and operations specialists. Together, we’re embarked on building one of the most formative cannabis companies that is bridging the gap between cannabis and science.”
Read the full article by Warren Bobrow here.